Digipath Labs’ mission is to provide pharmaceutical-grade analysis and testing to the cannabis industry to ensure consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client’s products through research, development, and standardization.

Digipath Labs screens medicinal grade hemp and CBD product for its quality, potency, and cannabinoid and terpenoid profiles, as well as potentially harmful contaminants, including:Microbial contaminants (incl E. coli, salmonella, Aspergillus, and fungi)Biological toxins (such as mycotoxins, aflatoxins, and ocratoxins)Heavy metals (incl mercury, arsenic, lead, and cadmium)Residual solvents (for non-CO2 extracts)Total aerobic bacteria countGram negative bacteriaMold and yeastPesticides

Laboratory testing is one of the vital platform technologies in the hemp and CBD marketplaces and must become standardized, consistent, and robust in order to maintain the long term health of the cannabis industry. From its inception, Digipath Labs’ mission has been to facilitate an industry-wide mandate that organic industrial hemp adhere to the same standards as other food and drug markets. A diverse array of assays and state-of-the-art, FDA-compliant lab equipment enables the Company to accurately test cannabis in accordance with Good Lab Practices.